BOUT
BOUT
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various...
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ELVN | Enliven Therapeutics, Inc. | 7.04% | 22.29K | $1.14M |
 APGE | Apogee Therapeutics, Inc. | 6.96% | 8.51K | $1.13M |
 USB | U.S. Bancorp | 6.92% | 18.23K | $1.12M |
 MIRM | Mirum Pharmaceuticals, Inc. | 6.88% | 9.32K | $1.11M |
 BCAX | Bicara Therapeutics Inc. Common Stock | 6.76% | 39.38K | $1.09M |
 GS | The Goldman Sachs Group, Inc. | 6.43% | 924 | $1.04M |
 UBS | UBS Group AG | 6.16% | 18.73K | $996.30K |
 BAC | Bank of America Corporation | 6.05% | 16.34K | $978.51K |
 PH | Parker-Hannifin Corporation | 5.98% | 1.01K | $967.19K |
 PNC | The PNC Financial Services Group, Inc. | 5.97% | 3.88K | $965.57K |
 BNY | Bank of New York Mellon Corp | 4.04% | 4.28K | $653.42K |
 FULT | Fulton Financial Corporation | 3.98% | 26.90K | $643.72K |
 TILE | Interface, Inc. | 3.93% | 19.56K | $635.63K |
 VIK | Viking Holdings Ltd | 3.91% | 6.56K | $632.39K |
 LLY | Eli Lilly and Company | 3.84% | 546 | $621.07K |
 AX | Axos Financial, Inc. | 1.99% | 3.33K | $321.86K |
 APH | Amphenol Corporation | 1.98% | 2.04K | $320.24K |
 NWG | NatWest Group plc | 1.93% | 18.30K | $312.15K |
 CGNX | Cognex Corporation | 1.93% | 4.86K | $312.15K |
 SHC | Sotera Health Company | 1.92% | 17.65K | $310.54K |
SECTOR HOLDINGS
Technology
Financial Services
Basic Materials
Consumer Cyclical
Healthcare
Consumer Defensive
Energy
Real Estate
Communication Services
IndustrialsASSET ALLOCATION BY REGION
United States
Switzerland
Bermuda
Hong Kong
Peru
United Kingdom
NetherlandsSECTOR HOLDINGS
Technology Financial Services Basic Materials Consumer Cyclical Healthcare Consumer Defensive Energy Real Estate Communication Services IndustrialsASSET ALLOCATION BY REGION
United States Switzerland Bermuda Hong Kong Peru United Kingdom NetherlandsHoldings (Top 20)
ELVN
Enliven Therapeutics, Inc.
APGE
Apogee Therapeutics, Inc.
USB
U.S. Bancorp
MIRM
Mirum Pharmaceuticals, Inc.
BCAX
Bicara Therapeutics Inc. Common Stock
GS
The Goldman Sachs Group, Inc.
UBS
UBS Group AG
BAC
Bank of America Corporation
PH
Parker-Hannifin Corporation
PNC
The PNC Financial Services Group, Inc.
BNY
Bank of New York Mellon Corp
FULT
Fulton Financial Corporation
TILE
Interface, Inc.
VIK
Viking Holdings Ltd
LLY
Eli Lilly and Company
AX
Axos Financial, Inc.
APH
Amphenol Corporation
NWG
NatWest Group plc
CGNX
Cognex Corporation
SHC
Sotera Health Company